Drug · DIN 02444844
BASAGLAR
CARTRIDGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 18, 2015; first marketed December 18, 2015.
- Drug Identification Number (DIN)
- 02444844
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin glargine A10AE04
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN GLARGINE | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2015: NOC 17245New Drug Submission (NDS)
Other DINs named BASAGLAR
- DIN 02461528 · Marketed
- DIN 02444852 · Cancelled Post Market